NAB PACLID 100 mg Injection (Albumin‑Bound Paclitaxel) is a prescription chemotherapy medicine used to treat advanced metastatic breast cancer, non‑small cell lung cancer (NSCLC), and metastatic pancreatic adenocarcinoma. This formulation combines paclitaxel with albumin nanoparticles (nab‑paclitaxel), helping the drug reach cancer cells more effectively while reducing certain solvent‑related side effects that occur with conventional paclitaxel. NAB PACLID is given by intravenous infusion under medical supervision, often as part of multi‑drug regimens in oncology clinics or hospitals. Regular monitoring for blood counts and organ function is required throughout treatment. Available in Pakistan and global markets with pricing that varies by brand and supplier; a valid doctor’s prescription is required to purchase and administer this medicine safely.